Vitamin D supplementation and clinical outcomes in COVID-19: a systematic review and meta-analysis.

Pal, R; Banerjee, M; Bhadada, S K; Shetty, A J; Singh, B; Vyas, A

Pal, R; Banerjee, M; Bhadada, S K; Shetty, A J; Singh, B; Vyas, A.

Afiliação

Pal R; Department of Endocrinology, Post Graduate Institute of Medical Education and Research, Chandigarh, 160012, India.
Banerjee M; Department of Endocrinology, Institute of Postgraduate Medical Education and Research, Kolkata, 700020, India.
Bhadada SK; Department of Endocrinology, Post Graduate Institute of Medical Education and Research, Chandigarh, 160012, India. bhadadask@rediffmail.com.
Shetty AJ; Department of Endocrinology, Post Graduate Institute of Medical Education and Research, Chandigarh, 160012, India.
Singh B; Government Medical College, Patiala, 147001, India.
Vyas A; Department of Medicine, Rabindranath Tagore Medical College, Udaipur, 313001, India.

J Endocrinol Invest ; 45(1): 53-68, 2022 Jan.

Article em En | MEDLINE | ID: mdl-34165766

Assuntos

Tratamento Farmacológico da COVID-19; SARS-CoV-2; Resultado do Tratamento; Vitamina D/administração & dosagem; COVID-19/epidemiologia; COVID-19/mortalidade; Comorbidade; Suplementos Nutricionais; Humanos; Unidades de Terapia Intensiva; Razão de Chances; Vitamina D/efeitos adversos; Deficiência de Vitamina D/epidemiologia

Palavras-chave

COVID-19; ICU admission; Mortality; Vitamin D

Texto completo

Imprimir

XML

PubMed Links

Buscar no Google

Texto completo: 1 Base de dados: MEDLINE Assunto principal: Vitamina D / Resultado do Tratamento / SARS-CoV-2 / Tratamento Farmacológico da COVID-19 Idioma: En Ano de publicação: 2022 Tipo de documento: Article

Texto completo

Imprimir

XML

PubMed Links

Buscar no Google